English
简体中文
Total: £ 56.28
Published Date: 2025-05-02 | Pages: 84 | Tables: 86 | Medical Care
The global market for Solutions for Biopharma was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Solutions for Biopharma is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Solutions for Biopharma is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Solutions for Biopharma in Biotechnology Company is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Solutions for Biopharma include Mckesson, Cardinal Health, Definitive Healthcare, Baxter, Almac Group, SHIMADZU, SOPHiA GENETICS, PwC, QIAGEN, IQVIA Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Solutions for Biopharma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Solutions for Biopharma.
The Solutions for Biopharma market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Solutions for Biopharma market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Solutions for Biopharma companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mckesson
Cardinal Health
Definitive Healthcare
Baxter
Almac Group
SHIMADZU
SOPHiA GENETICS
PwC
QIAGEN
IQVIA Inc
Syneos Health
BioPharma Services Inc.
Getinge
Akoya Biosciences, Inc
Accenture
Segment by Type
Product Research and Discovery
Clinical Trials and Development
Product Cycle Management
Others
Segment by Application
Biotechnology Company
Pharmaceutical Company
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Solutions for Biopharma company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Solutions for Biopharma Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Product Research and Discovery
1.2.3 Clinical Trials and Development
1.2.4 Product Cycle Management
1.2.5 Others
1.3 Market by Application
1.3.1 Global Solutions for Biopharma Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biotechnology Company
1.3.3 Pharmaceutical Company
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Solutions for Biopharma Market Perspective (2020-2031)
2.2 Global Solutions for Biopharma Growth Trends by Region
2.2.1 Global Solutions for Biopharma Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Solutions for Biopharma Historic Market Size by Region (2020-2025)
2.2.3 Solutions for Biopharma Forecasted Market Size by Region (2026-2031)
2.3 Solutions for Biopharma Market Dynamics
2.3.1 Solutions for Biopharma Industry Trends
2.3.2 Solutions for Biopharma Market Drivers
2.3.3 Solutions for Biopharma Market Challenges
2.3.4 Solutions for Biopharma Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Solutions for Biopharma Players by Revenue
3.1.1 Global Top Solutions for Biopharma Players by Revenue (2020-2025)
3.1.2 Global Solutions for Biopharma Revenue Market Share by Players (2020-2025)
3.2 Global Solutions for Biopharma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Solutions for Biopharma Revenue
3.4 Global Solutions for Biopharma Market Concentration Ratio
3.4.1 Global Solutions for Biopharma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Solutions for Biopharma Revenue in 2024
3.5 Global Key Players of Solutions for Biopharma Head office and Area Served
3.6 Global Key Players of Solutions for Biopharma, Product and Application
3.7 Global Key Players of Solutions for Biopharma, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Solutions for Biopharma Breakdown Data by Type
4.1 Global Solutions for Biopharma Historic Market Size by Type (2020-2025)
4.2 Global Solutions for Biopharma Forecasted Market Size by Type (2026-2031)
5 Solutions for Biopharma Breakdown Data by Application
5.1 Global Solutions for Biopharma Historic Market Size by Application (2020-2025)
5.2 Global Solutions for Biopharma Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Solutions for Biopharma Market Size (2020-2031)
6.2 North America Solutions for Biopharma Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Solutions for Biopharma Market Size by Country (2020-2025)
6.4 North America Solutions for Biopharma Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Solutions for Biopharma Market Size (2020-2031)
7.2 Europe Solutions for Biopharma Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Solutions for Biopharma Market Size by Country (2020-2025)
7.4 Europe Solutions for Biopharma Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Solutions for Biopharma Market Size (2020-2031)
8.2 Asia-Pacific Solutions for Biopharma Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Solutions for Biopharma Market Size by Region (2020-2025)
8.4 Asia-Pacific Solutions for Biopharma Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Solutions for Biopharma Market Size (2020-2031)
9.2 Latin America Solutions for Biopharma Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Solutions for Biopharma Market Size by Country (2020-2025)
9.4 Latin America Solutions for Biopharma Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Solutions for Biopharma Market Size (2020-2031)
10.2 Middle East & Africa Solutions for Biopharma Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Solutions for Biopharma Market Size by Country (2020-2025)
10.4 Middle East & Africa Solutions for Biopharma Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Mckesson
11.1.1 Mckesson Company Details
11.1.2 Mckesson Business Overview
11.1.3 Mckesson Solutions for Biopharma Introduction
11.1.4 Mckesson Revenue in Solutions for Biopharma Business (2020-2025)
11.1.5 Mckesson Recent Development
11.2 Cardinal Health
11.2.1 Cardinal Health Company Details
11.2.2 Cardinal Health Business Overview
11.2.3 Cardinal Health Solutions for Biopharma Introduction
11.2.4 Cardinal Health Revenue in Solutions for Biopharma Business (2020-2025)
11.2.5 Cardinal Health Recent Development
11.3 Definitive Healthcare
11.3.1 Definitive Healthcare Company Details
11.3.2 Definitive Healthcare Business Overview
11.3.3 Definitive Healthcare Solutions for Biopharma Introduction
11.3.4 Definitive Healthcare Revenue in Solutions for Biopharma Business (2020-2025)
11.3.5 Definitive Healthcare Recent Development
11.4 Baxter
11.4.1 Baxter Company Details
11.4.2 Baxter Business Overview
11.4.3 Baxter Solutions for Biopharma Introduction
11.4.4 Baxter Revenue in Solutions for Biopharma Business (2020-2025)
11.4.5 Baxter Recent Development
11.5 Almac Group
11.5.1 Almac Group Company Details
11.5.2 Almac Group Business Overview
11.5.3 Almac Group Solutions for Biopharma Introduction
11.5.4 Almac Group Revenue in Solutions for Biopharma Business (2020-2025)
11.5.5 Almac Group Recent Development
11.6 SHIMADZU
11.6.1 SHIMADZU Company Details
11.6.2 SHIMADZU Business Overview
11.6.3 SHIMADZU Solutions for Biopharma Introduction
11.6.4 SHIMADZU Revenue in Solutions for Biopharma Business (2020-2025)
11.6.5 SHIMADZU Recent Development
11.7 SOPHiA GENETICS
11.7.1 SOPHiA GENETICS Company Details
11.7.2 SOPHiA GENETICS Business Overview
11.7.3 SOPHiA GENETICS Solutions for Biopharma Introduction
11.7.4 SOPHiA GENETICS Revenue in Solutions for Biopharma Business (2020-2025)
11.7.5 SOPHiA GENETICS Recent Development
11.8 PwC
11.8.1 PwC Company Details
11.8.2 PwC Business Overview
11.8.3 PwC Solutions for Biopharma Introduction
11.8.4 PwC Revenue in Solutions for Biopharma Business (2020-2025)
11.8.5 PwC Recent Development
11.9 QIAGEN
11.9.1 QIAGEN Company Details
11.9.2 QIAGEN Business Overview
11.9.3 QIAGEN Solutions for Biopharma Introduction
11.9.4 QIAGEN Revenue in Solutions for Biopharma Business (2020-2025)
11.9.5 QIAGEN Recent Development
11.10 IQVIA Inc
11.10.1 IQVIA Inc Company Details
11.10.2 IQVIA Inc Business Overview
11.10.3 IQVIA Inc Solutions for Biopharma Introduction
11.10.4 IQVIA Inc Revenue in Solutions for Biopharma Business (2020-2025)
11.10.5 IQVIA Inc Recent Development
11.11 Syneos Health
11.11.1 Syneos Health Company Details
11.11.2 Syneos Health Business Overview
11.11.3 Syneos Health Solutions for Biopharma Introduction
11.11.4 Syneos Health Revenue in Solutions for Biopharma Business (2020-2025)
11.11.5 Syneos Health Recent Development
11.12 BioPharma Services Inc.
11.12.1 BioPharma Services Inc. Company Details
11.12.2 BioPharma Services Inc. Business Overview
11.12.3 BioPharma Services Inc. Solutions for Biopharma Introduction
11.12.4 BioPharma Services Inc. Revenue in Solutions for Biopharma Business (2020-2025)
11.12.5 BioPharma Services Inc. Recent Development
11.13 Getinge
11.13.1 Getinge Company Details
11.13.2 Getinge Business Overview
11.13.3 Getinge Solutions for Biopharma Introduction
11.13.4 Getinge Revenue in Solutions for Biopharma Business (2020-2025)
11.13.5 Getinge Recent Development
11.14 Akoya Biosciences, Inc
11.14.1 Akoya Biosciences, Inc Company Details
11.14.2 Akoya Biosciences, Inc Business Overview
11.14.3 Akoya Biosciences, Inc Solutions for Biopharma Introduction
11.14.4 Akoya Biosciences, Inc Revenue in Solutions for Biopharma Business (2020-2025)
11.14.5 Akoya Biosciences, Inc Recent Development
11.15 Accenture
11.15.1 Accenture Company Details
11.15.2 Accenture Business Overview
11.15.3 Accenture Solutions for Biopharma Introduction
11.15.4 Accenture Revenue in Solutions for Biopharma Business (2020-2025)
11.15.5 Accenture Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Solutions for Biopharma Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Product Research and Discovery
Table 3. Key Players of Clinical Trials and Development
Table 4. Key Players of Product Cycle Management
Table 5. Key Players of Others
Table 6. Global Solutions for Biopharma Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Solutions for Biopharma Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Solutions for Biopharma Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Solutions for Biopharma Market Share by Region (2020-2025)
Table 10. Global Solutions for Biopharma Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Solutions for Biopharma Market Share by Region (2026-2031)
Table 12. Solutions for Biopharma Market Trends
Table 13. Solutions for Biopharma Market Drivers
Table 14. Solutions for Biopharma Market Challenges
Table 15. Solutions for Biopharma Market Restraints
Table 16. Global Solutions for Biopharma Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Solutions for Biopharma Market Share by Players (2020-2025)
Table 18. Global Top Solutions for Biopharma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solutions for Biopharma as of 2024)
Table 19. Ranking of Global Top Solutions for Biopharma Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Solutions for Biopharma Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Solutions for Biopharma, Headquarters and Area Served
Table 22. Global Key Players of Solutions for Biopharma, Product and Application
Table 23. Global Key Players of Solutions for Biopharma, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Solutions for Biopharma Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Solutions for Biopharma Revenue Market Share by Type (2020-2025)
Table 27. Global Solutions for Biopharma Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Solutions for Biopharma Revenue Market Share by Type (2026-2031)
Table 29. Global Solutions for Biopharma Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Solutions for Biopharma Revenue Market Share by Application (2020-2025)
Table 31. Global Solutions for Biopharma Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Solutions for Biopharma Revenue Market Share by Application (2026-2031)
Table 33. North America Solutions for Biopharma Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Solutions for Biopharma Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Solutions for Biopharma Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Solutions for Biopharma Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Solutions for Biopharma Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Solutions for Biopharma Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Solutions for Biopharma Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Solutions for Biopharma Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Solutions for Biopharma Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Solutions for Biopharma Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Solutions for Biopharma Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Solutions for Biopharma Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Solutions for Biopharma Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Solutions for Biopharma Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Solutions for Biopharma Market Size by Country (2026-2031) & (US$ Million)
Table 48. Mckesson Company Details
Table 49. Mckesson Business Overview
Table 50. Mckesson Solutions for Biopharma Product
Table 51. Mckesson Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)
Table 52. Mckesson Recent Development
Table 53. Cardinal Health Company Details
Table 54. Cardinal Health Business Overview
Table 55. Cardinal Health Solutions for Biopharma Product
Table 56. Cardinal Health Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)
Table 57. Cardinal Health Recent Development
Table 58. Definitive Healthcare Company Details
Table 59. Definitive Healthcare Business Overview
Table 60. Definitive Healthcare Solutions for Biopharma Product
Table 61. Definitive Healthcare Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)
Table 62. Definitive Healthcare Recent Development
Table 63. Baxter Company Details
Table 64. Baxter Business Overview
Table 65. Baxter Solutions for Biopharma Product
Table 66. Baxter Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)
Table 67. Baxter Recent Development
Table 68. Almac Group Company Details
Table 69. Almac Group Business Overview
Table 70. Almac Group Solutions for Biopharma Product
Table 71. Almac Group Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)
Table 72. Almac Group Recent Development
Table 73. SHIMADZU Company Details
Table 74. SHIMADZU Business Overview
Table 75. SHIMADZU Solutions for Biopharma Product
Table 76. SHIMADZU Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)
Table 77. SHIMADZU Recent Development
Table 78. SOPHiA GENETICS Company Details
Table 79. SOPHiA GENETICS Business Overview
Table 80. SOPHiA GENETICS Solutions for Biopharma Product
Table 81. SOPHiA GENETICS Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)
Table 82. SOPHiA GENETICS Recent Development
Table 83. PwC Company Details
Table 84. PwC Business Overview
Table 85. PwC Solutions for Biopharma Product
Table 86. PwC Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)
Table 87. PwC Recent Development
Table 88. QIAGEN Company Details
Table 89. QIAGEN Business Overview
Table 90. QIAGEN Solutions for Biopharma Product
Table 91. QIAGEN Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)
Table 92. QIAGEN Recent Development
Table 93. IQVIA Inc Company Details
Table 94. IQVIA Inc Business Overview
Table 95. IQVIA Inc Solutions for Biopharma Product
Table 96. IQVIA Inc Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)
Table 97. IQVIA Inc Recent Development
Table 98. Syneos Health Company Details
Table 99. Syneos Health Business Overview
Table 100. Syneos Health Solutions for Biopharma Product
Table 101. Syneos Health Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)
Table 102. Syneos Health Recent Development
Table 103. BioPharma Services Inc. Company Details
Table 104. BioPharma Services Inc. Business Overview
Table 105. BioPharma Services Inc. Solutions for Biopharma Product
Table 106. BioPharma Services Inc. Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)
Table 107. BioPharma Services Inc. Recent Development
Table 108. Getinge Company Details
Table 109. Getinge Business Overview
Table 110. Getinge Solutions for Biopharma Product
Table 111. Getinge Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)
Table 112. Getinge Recent Development
Table 113. Akoya Biosciences, Inc Company Details
Table 114. Akoya Biosciences, Inc Business Overview
Table 115. Akoya Biosciences, Inc Solutions for Biopharma Product
Table 116. Akoya Biosciences, Inc Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)
Table 117. Akoya Biosciences, Inc Recent Development
Table 118. Accenture Company Details
Table 119. Accenture Business Overview
Table 120. Accenture Solutions for Biopharma Product
Table 121. Accenture Revenue in Solutions for Biopharma Business (2020-2025) & (US$ Million)
Table 122. Accenture Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Solutions for Biopharma Picture
Figure 2. Global Solutions for Biopharma Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Solutions for Biopharma Market Share by Type: 2024 VS 2031
Figure 4. Product Research and Discovery Features
Figure 5. Clinical Trials and Development Features
Figure 6. Product Cycle Management Features
Figure 7. Others Features
Figure 8. Global Solutions for Biopharma Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Solutions for Biopharma Market Share by Application: 2024 VS 2031
Figure 10. Biotechnology Company Case Studies
Figure 11. Pharmaceutical Company Case Studies
Figure 12. Others Case Studies
Figure 13. Solutions for Biopharma Report Years Considered
Figure 14. Global Solutions for Biopharma Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Solutions for Biopharma Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Solutions for Biopharma Market Share by Region: 2024 VS 2031
Figure 17. Global Solutions for Biopharma Market Share by Players in 2024
Figure 18. Global Top Solutions for Biopharma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solutions for Biopharma as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Solutions for Biopharma Revenue in 2024
Figure 20. North America Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Solutions for Biopharma Market Share by Country (2020-2031)
Figure 22. United States Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Solutions for Biopharma Market Share by Country (2020-2031)
Figure 26. Germany Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Solutions for Biopharma Market Share by Region (2020-2031)
Figure 34. China Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Solutions for Biopharma Market Share by Country (2020-2031)
Figure 42. Mexico Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Solutions for Biopharma Market Share by Country (2020-2031)
Figure 46. Turkey Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Solutions for Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Mckesson Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)
Figure 50. Cardinal Health Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)
Figure 51. Definitive Healthcare Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)
Figure 52. Baxter Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)
Figure 53. Almac Group Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)
Figure 54. SHIMADZU Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)
Figure 55. SOPHiA GENETICS Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)
Figure 56. PwC Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)
Figure 57. QIAGEN Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)
Figure 58. IQVIA Inc Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)
Figure 59. Syneos Health Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)
Figure 60. BioPharma Services Inc. Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)
Figure 61. Getinge Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)
Figure 62. Akoya Biosciences, Inc Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)
Figure 63. Accenture Revenue Growth Rate in Solutions for Biopharma Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
